Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
5/23/2025
Recent Executive Moves
5/22/2025
NMPA Approves Bayer's Eylea 8 mg for nAMD
5/22/2025
China Approves Hengrui's Camrelizumab-Famitinib Combo
5/21/2025
China Approves InnoCare's Tafasitamab for R/R DLBCL
5/21/2025
China Surges Ahead in Oncology Licensing, GlobalData Reports
5/21/2025
China's Drugstores Decline Amid Boom in Online Healthcare
5/20/2025
Pfizer Enters into $6B Exclusive Licensing Agreement with 3SBio
5/20/2025
Evive Bio Partners with LENIS Farma to Expand Ryzneuta® Distribution ...
5/20/2025
JHM Secures Strategic Investment to Advance Synthetic Biology Innovati...
5/20/2025
WuXi Bio Transfers Leverkusen Facility to Terumo in €150 Million Deal
5/20/2025
SparX and Mitsubishi Tanabe Forge Strategic ADC Research Collaboration
5/20/2025
CSPC Pharma's JMT106 Approved for Clinical Trials in China and the U.S...
5/16/2025
US Push to Decouple from China May Spike Drug Costs, Experts Warn
5/16/2025
WuXi Biologics Offloads German Plant to Terumo, Refocuses on Singapore...
5/16/2025
SMEI: China's Pharmaceutical Industry Seeks Stability and Innovation A...
5/15/2025
NMPA Approves Novartis' Scemblix for First-Line Treatment of Chronic M...
5/14/2025
NMPA Approves IND for YL242: An ADC Targeting Soluble VEGF M
5/14/2025
Beam Secures RMAT Designation for BEAM-302, a Base Editing Therapy for...
5/14/2025
RemeGen's Disitamab Vedotin Plus Toripalimab Shows Promise for HER2-Po...
5/14/2025
CTTQ's Anlotinib-Penpulimab Combo Extends Survival in First-Line Advan...
5/14/2025
R&D Spending Rises at 276 Chinese Drugmakers Despite Revenue Pressures
5/13/2025
China Expands Geriatric Services at Major Hospitals as Elderly Populat...
5/12/2025
Lepu's Miracogen Launches Phase 3 Trial of Novel EGFR-Targeting ADC Co...
5/12/2025
METiS Eyes US$200M Hong Kong IPO as AI Drug Sector Heats Up
5/12/2025
Trump's Drug Pricing and the US-China Trade Deal: "Our Interests are D...
5/10/2025
~30% of Chinese Listed Pharma Cos Achieve Double Growth in Revenue and...
5/10/2025
China's BMI Fund Reports Big Surplus in Q1/2025
5/10/2025
Roche Invests Nearly $300M to Build Vabysmo Manufacturing Hub in Shang...
5/10/2025
Qilu Secures Greater China Rights to Minghui's B7-H3 ADC in $38M Deal
5/10/2025
China's Public Hospitals Grapple with Mounting Debt Amid Reforms and E...
Page:
3
/
359
Total number of articles:
10756
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit